FDA Approved: CLARITHROMYCIN — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a generic version of clarithromycin produced by Lannett Company, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Helicobacter Pylori Infection
• Maxillary Sinusitis
• Peptic Ulcer Disease
• Pharyngitis
• Skin and Soft Tissue Infections
• Tonsillitis

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

SUPPL AP for CLARITHROMYCIN (CLARITHROMYCIN)